Delivery Order SPE2DB22D2103-SPE2DB24FR8NY
Award Date
11/21/23
Potential Completion Date
11/22/23
Potential Value
$72K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,840.66 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024, with an ultimate completion date of November 27, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $21,341.03 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 5, 2022, with a completion date of July 6, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The $25,113.66 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 17, 2022 and was awarded on May 16, 2022. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC enables Amerisourcebergen to efficiently supply a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets, valued at $50,443.65. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a Firm Fixed Price Delivery Order that will be completed by November 1, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and...
This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The $4,375.66 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 31, 2023 and was awarded on July 28, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Myrbetriq ER 25 mg tablets to the Defense Logistics Agency (DLA). The $91,699.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on August 30, 2022, with an ultimate completion date of August 31, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
This federal contract award is for the delivery of Myrbetriq ER 50 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract has a ceiling value of $7,601.93 and is a firm fixed-price delivery order. It was awarded on January 26, 2022, with a completion date of January 27, 2022. The contract does not have a set-aside...
This federal contract award is for the delivery of Myrbetriq ER 50 MG tablets to the Defense Logistics Agency (DLA). The $4,290.72 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and was not designated as a set-aside contract. The contract has an ultimate completion date of May 19, 2023 and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Myrbetriq ER 50 mg tablets. The $36,235.89 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...